Blood-Based Biomarkers for Alzheimer Disease

JAMA 2026 Open access

Read full text
Authors: Heather E. Whitson, Nicole R. Fowler, Michelle M. Mielke
DOI: 10.1001/jama.2025.26049
Cited by: 5
References: 8

Abstract

This Viewpoint discusses areas of potential harm and actions needed to mitigate risk so that the use of blood-based biomarkers for Alzheimer disease can achieve the intended goal of improving care for all.

Fields of Study & Subjects

Alzheimer's disease research and treatments S100 Proteins and Annexins Biological Research and Disease Studies

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
335
Issue
8
Pages
663–663
Publication date
22 January 2026
Language
EN